A detailed history of Grey Street Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Grey Street Capital, LLC holds 19,414 shares of PFE stock, worth $516,800. This represents 0.07% of its overall portfolio holdings.

Number of Shares
19,414
Previous 9,776 98.59%
Holding current value
$516,800
Previous $281 Million 91.41%
% of portfolio
0.07%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 09, 2024

BUY
$25.89 - $29.73 $249,527 - $286,537
9,638 Added 98.59%
19,414 $539 Million
Q4 2023

Jan 11, 2024

SELL
$26.13 - $33.94 $9,903 - $12,863
-379 Reduced 3.73%
9,776 $281 Million
Q2 2023

Jul 13, 2023

BUY
$36.12 - $41.79 $65,015 - $75,222
1,800 Added 21.54%
10,155 $372 Million
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $329,103 - $428,444
8,355 New
8,355 $341 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Grey Street Capital, LLC Portfolio

Follow Grey Street Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grey Street Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grey Street Capital, LLC with notifications on news.